Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART: Trospium Chloride BBB Penetration in Elderly OAB
NCT00863551Phase 4Completed
- Sponsor
- Allergan
- Start
- Apr 2009
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of trospium in overactive bladder (OAB), sponsored by Allergan. Primary endpoint: Cerebral Spinal Fluid Levels of Trospium at Day 10, Hour 5. Started Apr 2009; status: completed.
02
Drugs
trospium
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00863551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00863551.